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Abstract  
Previously, we demonstrated that eicosapentaenoic acid enhanced ethanol-induced oxidative 
stress and cell death in primary rat hepatocytes via an increase in membrane fluidity and lipid 
raft clustering. In this context, another n-3 polyunsaturated fatty acid, docosahexaenoic acid 
(DHA), was tested with a special emphasis on physical and chemical alteration of lipid rafts. 
Pretreatment of hepatocytes with DHA reduced significantly ethanol-induced oxidative stress 
and cell death. DHA protection could be related to an alteration of lipid rafts. Indeed, rafts 
exhibited a marked increase in membrane fluidity and packing defects leading to the 
exclusion of a raft protein marker, flotillin. Furthermore, DHA strongly inhibited disulfide 
bridge formation, even in control cells, thus suggesting a disruption of protein-protein 
interactions inside lipid rafts. This particular spatial organization of lipid rafts due to DHA 
subsequently prevented the ethanol-induced lipid raft clustering. Such a prevention was then 
responsible for the inhibition of phospholipase C-γ translocation into rafts, and consequently 
of both lysosome accumulation and elevation in cellular low-molecular-weight iron content, a 
prooxidant factor. In total, the present study suggests that DHA supplementation could 
represent a new preventive approach for patients with alcoholic liver disease based upon 
modulation of the membrane structures.  
 
Keywords: Lipid rafts; n-3 polyunsaturated fatty acids; docosahexaenoic acid; ethanol; lipid 
peroxidation; oxidative stress.  
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1. Introduction 
Dietary long chain n-3 polyunsaturated fatty acids (n-3 PUFAs), such as docosahexaenoic 
acid (DHA) (C22:6, n-3) and eicosapentaenoic acid (EPA) (C20:5, n-3), found naturally in fat 
fish, have been reported to exhibit beneficial effects in the prevention and treatment of a great 
variety of human diseases (Calder and Yaqoob, 2009), including inflammatory and 
autoimmune disorders (Simopoulos, 2002), cancer (Calviello et al., 2009), cardiovascular 
diseases (Bei et al., 2011), retinopathy (Pawlik et al., 2011) and neurological diseases (Assisi 
et al., 2006; Dyall and Michael-Titus, 2008). However, we recently demonstrated that EPA 
was capable of enhancing ethanol-induced oxidative stress and cell death in rat hepatocytes 
via an exacerbation of membrane remodeling (Aliche-Djoudi et al., 2011). Ethanol 
metabolism, by producing a mild oxidative stress, increased membrane fluidity (Sergent et 
al., 2005) and triggered lipid raft clustering, which in turn strikingly enhanced oxidative 
stress via activation of the phospholipase C signaling pathway (Nourissat et al., 2008). Lipid 
rafts are highly ordered plasma membrane microdomains, enriched in cholesterol and 
sphingolipids, that form signaling platforms following clustering (Simons and Toomre, 
2000). Interestingly, n-3 PUFAs have been extensively described as modifying the lipid and 
protein composition of lipid rafts in many cell types such as T lymphocytes (Fan et al., 2004; 
Stulnig, 2000), Caco-2 cells (Duraisamy et al., 2007), retinal vascular endothelial cells (Chen 
et al., 2007), macrophages (Wong et al., 2009), and human breast cancer cells (Schley et al., 
2007). In this context, the nutritional significance of lipid rafts has been recently pointed out 
(Yaqoob and Shaikh, 2010). Our results about the toxicity of EPA (Aliche-Djoudi et al., 
2011) were in line with those obtained by others in vivo in rats or mice, but none of these 
latter studies focused on lipid rafts. Thus, in rats chronically fed simultaneously with fish oil 
and ethanol, an increase in pathology severity (inflammation and necrosis) associated with a 
rise in lipid peroxidation was observed compared to rats fed with corn oil instead of fish oil 
(Nanji et al., 1994). In addition, fish oil-ethanol rats exhibited the highest level of apoptotic 
cells (Yacoub et al., 1995), and of pro-inflammatory cytokine messenger RNAs (Nanji et al., 
1999) in the liver. Increased oxidative stress was inversely related to antioxidant enzyme 
activities and expression in the liver (Polavarapu et al., 1998). Finally, it was also 
demonstrated that fish oil can synergize with ethanol for the collagen release depending on 
lipid peroxidation (Nieto, 2007). In contrast, several research teams (Song et al., 2008 ; Wada 
et al., 2008; Huang et al., 2013) reported that small amounts of DHA or fish oil were able to 
protect from ethanol-induced fatty liver, oxidative stress, mitochondrial dysfunction and 
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necrosis in rodents. However, none of these studies dealing with the beneficial effect of n-3 
PUFAs on ethanol-induced liver damage looked for the role of lipid rafts, although several 
studies supported the involvement of these microdomains in the effects of n-3 PUFAs on 
inflammatory response of lymphocytes (Shaikh and Teague, 2012), endothelial dysfunction 
(Ye et al., 2010), cancer cell growth (Rogers et al., 2010), and hepatic ischemia/reperfusion 
injury (Kim et al., 2014). Because of the discrepancies regarding the role of PUFAs towards 
ethanol-induced liver toxicity, and based upon the increasing body of evidence about the 
beneficial effects of these compounds on human health, we decided to test another n-3 PUFA, 
namely DHA, in the context of a lipid-raft dependent toxicity of ethanol in rat hepatocytes. In 
addition, we evaluated the possible physical and chemical alteration of lipid rafts by DHA. In 
this paper, DHA was shown to modify lipid rafts, thereby protecting hepatocytes from 
ethanol-induced oxidative stress and cell death. 
 
2. Materials and Methods 
2.1. Chemicals 
Eagle minimum essential medium and medium 199 with Hanks’ salts were purchased from 
Gibco, Invitrogen, (Cergy - Pontoise, France). Bovine serum albumin and fetal calf serum 
were obtained from Biowest (Nuaille, France). Liberase was from Roche Diagnostics 
(Meylan, France). Ethanol was obtained from Prolabo (Paris, France). Dehydroethidium 
(DHE), LysoTracker Red DND-99 (LTR) and cholera toxin subunit B (CTB) were provided 
by Molecular Probes, Invitrogen, (Cergy-Pontoise, France). Docosahexaenoic acid (DHA), 
12-doxyl stearic acid (12-DSA), Hoechst 33342, tetramethyl-4-maleimidopiperidine-1-oxyl 
(MAL-6) and p-nitrophenyl phosphate solution were all purchased from Sigma-Aldrich 
(Saint-Quentin Fallavier, France). O-(2,3,4,5,6-Pentafluorobenzyl)hydroxylamine 
hydrochloride (PFBHA.HCl) was purchased from Fluka (Montigny le Bretonneux, France). 
HNE-D3 was provided from SPI Bio (Saint-Quentin Fallavier, France). Deferiprone was 
from Acros (Fischer Scientific, Illkirch, France). Anti- phospholipase Cγ1, anti-flotillin and 
anti-malondialdehyde antibodies were purchased from Upstate (Millipore, Saint-Quentin –
Les Yvelines, France), BD Biosciences (Le Pont de Claix, France) and Abcam (Paris, 
France), respectively. Anti-mouse and anti-rabbit immunoglobulin G (IgG) was from DAKO 
(Trappes, France).  
 
2.2. Cell isolation and cultures 
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Adult rat hepatocytes were isolated from 2-months-old Sprague-Dawley animals by perfusion 
of the liver as previously described, except that a liberase solution (17 g/ml) was used for 
dissociation of liver parenchymal cells instead of a collagenase solution (Guguen-Guillouzo 
et al., 1983). In most cases, cell viability was above 90 %. Cells were seeded at densities of 2 
x 106 in 9.6 cm2 petri dishes (cell death determination, immunofluorescence staining of cells 
and antioxidant content), 3 x 104 cells/well in 96-well microplates (lysosome quantification), 
10 x 106 cells in 78 cm2 petri dishes (membrane fluidity determination), 20 x106 cells in 176 
cm2 petri dishes (low-molecular-weight iron measurement and lipid raft isolation). They were 
then cultured in a medium composed of 75 % Eagle minimum essential medium and 25 % 
medium 199 with Hanks' salts, supplemented with 10 % fetal calf serum and containing 
streptomycin (50 g), penicillin (5 g), insulin (5 g), bovine serum albumin (1 mg), and 
NaHCO3 (2.2 mg) per milliliter. Cells were kept at 37°C in an atmosphere of 5% CO2 and 
95% air. The medium was changed 3 hours after seeding and substituted with the same 
medium as above but deprived of serum. Regarding culture treatments, DHA at a final 
concentration of 200 M was added or not to rat hepatocytes. This concentration was chosen 
in order to be as close as possible to that detected in plasma after dietary supplementation 
(around 500 µM) (Wander and Du, 2000). In addition, no further protection against ethanol-
induced apoptosis was observed at 300 or 500 µM DHA concentrations (data not shown). 
After an 18-hours incubation time at 37°C, some cultures were supplemented with 50 mM 
ethanol for 1, 1.5 or 5 hours, while cultures treated with DHA vehicle (methanol 0.12%) were 
used as controls. 
 
2.3. Lipid Raft Fractionation by Flotation Method 
Lipid rafts are defined as being resistant towards solubilization by nonionic detergents at low 
temperature. Based on this property, lipid rafts float and concentrate in low-density sucrose 
gradient upon centrifugation. Thus, adapted from a previously described method (Nourissat et 
al., 2008), lipid raft fractions were prepared by discontinuous sucrose gradient 
ultracentrifugation of hepatocyte lysates obtained following treatment with the detergent 
Triton X 100 at 1%. Eleven 1-ml fractions were collected from the top of the gradient and 
then analyzed for protein and lipid content. In some experiments, the whole raft fractions 
(fractions 1 to 6) were gathered, diluted in PBS and pelleted by another ultracentrifugation at 
41000 rpm for 16-20 hours at 4°C in an SW41 rotor. This latter procedure allowed us to pool 
lipid rafts in a single pellet. 
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2.4. Biochemical analysis of membrane lipid rafts  
2.4.1. Lipid assays. The cholesterol content of each gradient fraction was 
spectrophotometrically evaluated by a cholesterol oxidase/peroxidase assay using the Infinity 
Cholesterol kit (Thermo Electron Corp., Eragny sur Oise, France) after lipid extraction by a 
chloroform/methanol mixture (2:1 vol/vol), according to the method of Folch. Total fatty 
acids were analyzed by gas chromatography equipped with a flame ionization detector after 
lipid extraction by a hexane/isopropanol mixture (3:2 vol/vol), saponification and 
methylation of each raft fraction (Aliche-Djoudi et al., 2011). 
 
2.4.2. Protein assays. Flotillin-1 expression was analyzed by western blotting with 1:1000 
mouse antiflotillin-1 monoclonal antibody (Nourissat et al., 2008). Alkaline phosphatase activity 
was determined by a colorimetric method using p-nitrophenylphosphate as a substrate 
(Nourissat et al., 2008). 
 
2.5. Determination of structural alterations of lipid rafts  
2.5.1. Spin labeling techniques. Using paramagnetic reporter groups incorporated into lipid 
rafts, Electron Paramagnetic Resonance (EPR) spectroscopy can evaluate both changes in 
membrane fluidity and protein interactions. Membrane fluidity was measured, as previously 
described (Nourissat et al., 2008) using the spin label, 12-doxyl stearic acid. The fluidity of 
the labeled membranes was quantified by calculating the order parameter S, which is 
inversely related to membrane fluidity. Protein structural changes were examined using 
tetramethyl-4-maleimidopiperidine-1-oxyl (MAL-6), a thiol-specific protein spin label 
(Nourissat et al., 2008). The relevant EPR parameter used for the evaluation of protein 
structural changes is the ratio of the height (W) of the low-field weakly immobilized line to 
the height (S) of the low-field strongly immobilized line. A decrease in the W/S ratio reveals 
conformational compactions or increased interactions between membrane proteins (Hensley 
et al., 1994). 
2.5.2. Fluorescent staining of lipid rafts. Lipid rafts were stained by the binding of the 
cholera toxin subunit B coupled to green fluorescent Alexa Fluor 488 conjugate to the 
pentasaccharide chain of the lipid raft marker monosialotetrahexosyl ganglioside (GM1), 
using the Vybrant Lipid Raft Labeling kit (Molecular Probes, Invitrogen, Cergy-Pontoise, 
France) as previously described (Nourissat et al., 2008). When dual staining was performed, 
hepatocytes were incubated with both cholera toxin conjugate and the primary monoclonal 
anti-phospholipase Cγ1 antibody (10 g/ml) for 2 hours, followed by incubation with 1:2000 
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TRITC-conjugated anti-mouse immunoglobulin G secondary antibody for an additional 2 
hours (Nourissat et al., 2008). Individual and overlay fluorescence were shown following 
deconvolution analysis using Metavue software.  
 
2.6. Oxidative stress evaluation 
2.6.1. Determination of reactive oxygen species (ROS) production. Intracellular levels of 
ROS were measured as previously described (Sergent et al., 2005), except that another probe, 
dehydroethidium, was used instead of dihydrofluorescein diacetate.  
2.6.2. Evaluation of lipid peroxidation.  
Lipid peroxidation of rat hepatocytes was estimated by using the fluorescent probe, C11-
BODIPY 581/591, and by measuring free 4-hydroxynonenal. C11-BODIPY 581/591 shifts from 
red to green fluorescence upon oxidation. Briefly, fluorescence was recorded by a 
SpectraMax Gemini Spectrofluorimeter (Molecular Devices, France) using two couples of 
wavelengths to measure the amount of reduced (exc = 590 nm – em = 635 nm) and 
oxidized probe (exc = 485 nm – em = 535 nm) (Nourissat et al., 2008). Lipid peroxidation 
was then quantified by calculating the ratio oxidized probe/total probe.  
4-hydroxynonenal (4-HNE) is an α,β unsaturated aldehyde, secondary end-product of the 
oxidized polyunsaturated fatty acid degradation. Briefly, hepatocytes were lysed and 
centrifuged at 5000 g for 5 min at 4 °C. Supernatant (200 µl) of each simple was mixed with 
50 µl of internal standard HNE-D3 (1 µg/mL). The pentafluorobenzyl-oxime derivatives (O-
PFB) of 4-HNE and of the internal standard were synthesized by adding 200 L of O-
(2,3,4,5,6-pentafluorobenzyl)hydroxylamine hydrochloride (PFBHA·HCl) (12. 5 mg/ml). 
After incubation of the mixture at room temperature for 1 hour under shaking, 500 µl of 
methanol were added followed by 2 ml hexane addition. Then, sample was mixed with 140 µl 
of concentrated sulfuric acid to eliminate excess of PFBHA.HCl, before mixing and 
centrifugation of the sample at 3000 g for 5 min at 4 °C. After separation, hexane fractions 
were collected, dried over anhydrous sodium sulfate and evaporated under nitrogen at 50 °C 
for 5 min ; this was followed by silylation of hydroxyl group to trimethylsilyl ethers (TMS) 
by adding of 50 l of N,O-bis(trimethylsilyl)trifluoroacetamide and trimethylchlorosilane 
(BSTFA + TMCS) (99:1) (Supelco, Saint-Quentin Fallavier, France), for 15 min at 80 °C. 
Then, 50 µl of hexane was added to the sample, and the O-PFB-TMS derivative of 4-HNE 
was analyzed by gas chromatography-mass spectrometry (GC/MS) equipped with a capillary 
column [capillary column HP-5MS : (5 % phenyl)-methylpolysiloxane] (Agilent 19091S-
	

433, Agilent Technologies France, Massy) (30 m, 0.25 mm internal diameter, 0.25 m film 
thickness), and a mass spectrometry detector in the single ion monitoring (SIM) mode (Mass 
selective detector Hewlett Packard 5973, Agilent Technologies France, Massy). The column 
temperature program started at 60°C for 1 min, ramped at 20°C/min to 85°C, and then the 
temperature was increased to 300°C at 8°C/min.  
2.6.3. Measurement of low molecular weight iron. Intracellular low-molecular-weight-iron 
(LMW iron) was measured by EPR based upon the capacity of deferiprone to chelate only 
low-molecular-weight iron and to give a paramagnetic chelate, as previously described 
(Sergent et al., 1997). 
2.6.4. Estimation of intracellular antioxidants  
Reduced glutathione (GSH) levels, manganese superoxide dismutase (Mn SOD), Cu,Zn 
superoxide dismutase (Cu,Zn SOD) and glutathione peroxidase (GPx) activities were estimated 
using the Bioxytech GSH/GSSG-412 colorimetric assay kit (Oxis International, Tebu-Bio, Le 
Perray en Yveline, France), a superoxide dismutase activity kit (Assaydesigns, Stressgen, Paris, 
France), and the Biotech GPx -340 colorimetric assay kit (Oxis International, Tebu-Bio, Le 
Perray en Yveline, France), respectively. 
 
2.7. Evaluation of cell death by nuclear staining 
Chromatin condensation and morphological changes in the nucleus were observed using the 
chromatin dye Hoechst 33342. After a 5-hours incubation with ethanol, cells were stained in 
culture medium with 10 g/ml Hoechst 33342 in the dark for 30 minutes at 37 °C. Cells were 
then examined under fluorescence microscopy (Olympus BX60, France). Total population 
was always > 200 cells. 
 
2.8. Lysosome staining 
Lysosomes were labeled with LysoTracker Red, a red acidotropic fluoroprobe. At the end of 
each treatment, rat hepatocytes, cultured on glass coverslips, were incubated with 200 nM 
LysoTracker Red for 5 minutes at 37 °C. Cells were then fixed with 4% paraformaldehyde in 
PBS for 30 minutes at 4 °C. The red fluorescence of LysoTracker was visualized by 
fluorescence microscopy (DMRXA Leica, Germany).  
 
2.9. Statistical analysis 
Data are presented as mean ± SD and were analyzed using one-way ANOVA followed by a 
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Student-Newman-Keuls multiple comparison test. A value of p< 0.05 was considered 
statistically significant. 
 
3. Results 
3.1. Protective effect of DHA towards ethanol-induced cell death and oxidative stress in 
rat hepatocytes 
As previously shown (Nourissat et al., 2008), ethanol exposure of rat hepatocytes increased 
both cell death (Figure 1A) and oxidative stress as assessed by measuring ROS production 
(Figure 1B) and lipid peroxidation (Figures 1C-1D). DHA pretreatment inhibited all these 
effects. Treatment with DHA alone did not lead to any change in cell death and oxidative 
stress compared to control conditions. In order to further explore the DHA protective effect 
on oxidative stress, we decided to evaluate the levels of various antioxidants in hepatocytes. 
After pretreatment with DHA, no change in activities of Mn superoxide dismutase, Cu/Zn 
superoxide dismutase and glutathione peroxidase was detected except for glutathione 
concentration (Figure 2). Indeed, this concentration increased by nearly 16 % when compared 
to control cultures. No further elevation was detected when compared to ethanol alone.  
 
3.2. DHA-induced biochemical alterations of lipid rafts  
As we previously showed that ethanol toxicity in hepatocytes was closely related to 
biochemical and physical alterations of lipid rafts (Nourissat et al., 2008), we were then 
interested in looking for possible DHA effect on lipid rafts. 
 
3.2.1. Lipid composition of lipid rafts 
Gas chromatography analysis of fatty acid profiles showed that, as previously described 
(Aliche-Djoudi et al., 2011), lipid rafts from control rat hepatocytes were significantly 
enriched in saturated and monounsaturated fatty acids, while polyunsaturated fatty acids were 
less abundant (Figure 3A), testifying the high lipid–ordered state of these specialized 
membrane microdomains. Treatment of rat hepatocytes with DHA led to a significant 
increase in polyunsaturated fatty acids and a decrease in saturated fatty acids, while no 
significant change in monounsaturated fatty acids was observed (Figure 3A). Ethanol 
addition did not modify fatty acid profiles when compared to control hepatocytes or DHA 
pretreated cells (data not shown). When considering the DHA specific levels (Figure 3B), it 
was shown that DHA was incorporated into rafts in a greater proportion (+42%) compared to 
non-raft regions (+23 %), even if DHA is well-known to have a high steric incompatibility 
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with cholesterol, a major lipid raft component. Unexpectedly, DHA did not lead to any 
change in the cholesterol composition of lipid rafts (Figure 3C), like upon ethanol addition 
(control : 0.685 ± 0.032 µmol cholesterol/mg protein ; ethanol : 0.684 ± 0.031 µmol/mg 
protein ; DHA : 0.765 ± 0.15 ; ethanol + DHA : 0.751 ± 0.14 µmol/mg protein). Thus, it 
appears that, in hepatocytes, for this 50 mM concentration, ethanol did not lead to any lipid 
raft disruption, suggesting an apparent contradiction when considering literature. Indeed, an 
ethanol-induced disruption was previously established, but it was only for higher 
concentrations (200 mM) and only in macrophages (Fernandez-Lizarbe et al, 2007). For 
lower ethanol concentrations, in macrophages (Dai et al, 2005), monocytes (Dolganiuc et al, 
2006) or T lymphocytes (Ghare et al, 2011), no change in lipid raft protein markers was 
reported. 
 
3.2.2. Protein expression analysis of both soluble and detergent-resistant fractions 
Immunoblotting of both raft and non raft fractions with antibody against flotillin-1, a lipid 
raft protein marker, revealed that DHA induced a slight shift of flotillin-1 toward the non raft 
fractions (Figure 3D), suggesting an exclusion of flotillin from rafts or a lower resistance of 
lipid rafts to detergent solubilisation. 
 
4. DHA effect on the physical alteration of lipid raft induced by ethanol 
4.1. Membrane fluidity 
DHA increased membrane fluidity of lipid rafts compared to that of rafts obtained from 
control cells, but did not enhance ethanol-induced fluidization of lipid rafts (Figure 4A). 
Similarly, DHA did not modify ethanol-induced membrane fluidization of bulk membranes 
(Figure 4A).  
 
4.2. Lipid raft aggregation 
Lipid raft aggregation was determined by the staining of a lipid raft marker, ganglioside 
GM1, with green fluorescent-labeled cholera toxin B subunit. As previously shown 
(Nourissat et al., 2008), ethanol treatment induced lipid raft aggregation characterized by the 
accumulation of fluorescent-labeled cholera toxin B subunit1 as a punctuated pattern in the 
plasma membrane, indicative of a redistribution of ganglioside GM1 into clusters (Figure 
4B). In control hepatocytes, GM1 distributed throughout the membrane as indicated by the 
diffuse green fluorescence. DHA pretreatment inhibited ethanol-induced lipid aggregation, as 
exhibited by the diffuse green fluorescence pattern. To further understand how DHA 
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protected from ethanol-induced lipid raft clustering, we used MAL-6, a thiol-specific protein 
spin label, which can binds covalently to free sulfhydryl (SH) groups. A decrease in the W/S 
ratio reveals conformational compactions or increased interactions between membrane 
proteins (Hensley et al., 1994). A decrease in the W/S ratio was obtained in lipid rafts from 
ethanol-treated hepatocytes, which was previously ascribed to the raft protein oxidation and 
the formation of disulfide bridges between lipid rafts, thus promoting lipid raft aggregation 
(Nourissat et al., 2008). Pretreatment of rat hepatocytes with DHA considerably increased 
W/S ratio, even upon ethanol exposure, suggesting a reduction of disulfide bridges or a 
decrease in lipid raft compaction (Figure 4C).  
 
5. DHA inhibition of phospholipase Cγ1 (PLCγ1) relocation to lipid rafts was involved in 
the DHA protection against ethanol-induced oxidative stress and cell death.  
Following raft clustering, relocation of PI-PLCγ1 to lipid rafts was shown as allowing its own 
activation; this was necessary to enhance ethanol-induced oxidative stress and cell death via a 
lysosome accumulation and an increase in low molecular weight (LMW) iron content 
(Nourissat et al., 2008) (Aliche-Djoudi et al., 2011). These iron species are known to trigger 
oxidative stress by catalyzing the formation of a highly hydroxyl radical, via a Fenton or 
Haber-Weiss reaction, or more directly by the production of ferryl and perferryl species. 
These iron species are not contained in high-molecular-weight molecules such as ferritin or 
mitochondrial ferroproteins. 
As previously described for ethanol-treated hepatocytes, merging of fluorescence stainings 
led to the appearance of yellow patches, which indicated clustering or colocalization of 
PLCγ1 with GM1. When cells were pretreated with DHA prior to ethanol, the colocalization 
of PLCγ1 with GM1 was completely blocked (Figure 5A). In addition, DHA pretreatment 
also inhibited PLCγ1 activity. Indeed, alkaline phosphatase activity was significantly 
increased when cells were pretreated by DHA (Figure 5B). Alkaline phosphatase is a 
glycosylphosphatidylinositol (GPI)-anchored protein tethered to the outer leaflet of lipid raft 
that is known to be a target for PLCγ1. Thus, these results suggested that DHA inhibited both 
PLCγ1 relocation to rafts and its subsequent activation. As expected, DHA also prevented 
both the lysosome accumulation (Figure 6A) and the increase in cellular LMW iron content 
due to ethanol (Figure 6B).  
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6. Discussion  
In this study, docosahexaenoic acid (DHA), a n-3 PUFA, was demonstrated to protect from 
the ethanol induced-cell death of primary rat hepatocytes through inhibition of oxidative 
stress; this is in contrast to our previous results reporting the increase of ethanol toxicity upon 
exposure to another n-3 PUFA, namely eicosapentaenoic acid (EPA) (Aliche-Djoudi et al., 
2011). Our findings could explain the discrepancies observed in literature about the effects of 
fish oil or n-3 PUFAs on ethanol-induced liver toxicity. Indeed, when examining the studies 
describing a protection by n-3 PUFAs towards the oxidative/nitrosative stress or steatosis due 
to ethanol, it is noteworthy that it concerns an administration to rodents of DHA alone or fish 
oil containing a high proportion of DHA (Song et al., 2008; Wada et al., 2008; Huang et al, 
2013). In addition, Hayashi et al. (1999) also reported a protection when human received 
phospholipids containing a higher proportion of DHA than EPA. Finally, treatment of rats 
with DHA also protected from induced nonalcoholic steatohepatitis by decreasing oxidative 
stress (Takayama et al., 2010). At the opposite, the studies demonstrating an exacerbation of 
fatty liver, inflammation or fibrosis in rodents (Nanji et al., 1994, 1999; Nieto et al., 2007; 
Polavarapu et al., 1998; Yacoub et al., 1995) used fish oil with a higher proportion of EPA. 
These differences on ethanol liver toxicity as a function of the n-3 PUFA compound 
suggested that the relative amounts of EPA and DHA in diets or fish oil supplements may 
differentially modulate the progression of alcoholic liver disease. Such a differential effect 
for two compounds of a same fatty acid family might be surprising, but others also reported 
differential effects of EPA and DHA on cell functions (Gorjao et al., 2009) such as ion 
homeostasis, intracellular signaling or gene expression.  
In primary rat hepatocytes, the DHA beneficial effects as compared to the EPA toxic effects 
towards ethanol-induced liver toxicity could be related to differences in their physical 
properties within membranes. Indeed, DHA exposure of hepatocytes led to its incorporation 
both in lipid rafts and non-raft regions. Such a DHA incorporation into lipid rafts was also 
reported in vitro after DHA treatment of Jurkat T lymphocytes (Li et al., 2005), EL4 B 
lymphocytes (Shaikh et al., 2009), human retinal endothelial cells (Chen et al., 2007), Caco-2 
cells (Duraisamy et al., 2007), and in vivo in B lymphocytes of mice treated with fish oil 
(Rockett et al., 2012). In addition, based upon the DHA aversion for cholesterol (Wassal and 
Stillwell, 2009), one might have expected that DHA incorporation into lipid rafts would drive 
the cholesterol expulsion from them. However, in our cellular model, cholesterol levels did 
not change in lipid rafts in line with observations obtained in vitro (Shaikh et al., 2009) and in 
vivo (Rockett et al., 2012) in B lymphocytes. Using quantitative microscopy studies, these 
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authors also showed that DHA or fish oil increased lipid raft size, thus suggesting that DHA-
containing phospholipids would form their own distinct non raft regions on a nanometer scale 
within lipid rafts (Shaikh et al., 2009). In our model, by means of three approaches, the study 
of lipid raft structure supported this concept of lipid raft disorganization. First, flotillin was 
partially evicted from raft isolated by non-ionic detergent procedure suggesting a partial lipid 
raft disruption. Thus, it has been described that disturbance of polar or hydrophobic 
interactions inside lipid rafts induced transient packing defects that favor detergent 
solubilisation (Patra et al., 1998). In addition, DHA strongly decreased lipid raft compaction 
and perhaps the formation of disulfide bridges, even in control cells, thus suggesting a 
disruption of protein-protein interactions inside lipid rafts. Finally, lipid rafts exhibited a 
profound increase in membrane fluidity. This particular spatial organization of lipid rafts 
might be responsible for the DHA inhibition of ethanol-induced lipid raft aggregation. At the 
opposite, EPA toxic effect was found to be linked to its preferential incorporation in non-raft 
regions, which favored translocation of cholesterol to lipid rafts, thus enhancing lipid phase 
segregation between raft and non-raft domains and hence lipid raft clustering (Aliche-Djoudi 
et al., 2011). It should be added that, in a similar way, in model membranes, DHA was shown 
to incorporate more easily in lipid rafts than EPA (Williams et al, 2012). Furthermore in B 
lymphocytes, Shaikh et al. (2009) obtained inhibition of clustering with DHA but not with 
EPA. The DHA effect on lipid raft clustering had important consequences in terms of 
cytoprotection. Indeed, ethanol-induced oxidative stress was previously demonstrated to be 
related to this clustering which allowed the activation of PLC γ1 and then the elevation of 
LMW iron, a potent pro-oxidant factor, via an increase in lysosome number. Here, DHA was 
found to inhibit this process. In this context, one might assume for the first time, that DHA-
induced structural changes of lipid rafts could be the mechanism whereby this fatty acid 
protects liver from ethanol induced-toxicity. 
However, we cannot totally rule out the possibility that the DHA antioxidant effect would 
involve an increase in antioxidant levels, notably glutathione (Komatsu et al., 2003) and 
glutathione peroxidase (Joulain et al., 1994; Lemaitre et al., 1997), as previously described in 
various cell types including macrophages, platelets or monocytes. Indeed, DHA has been 
reported to trigger oxidative stress in endothelial cells, which in turn can induce the 
expression of glutathione peroxidase as an adaptive response (Delton-Vandenbroucke et al., 
2001). In addition, more recently, peroxidation products derived from DHA have been 
described to activate Nrf2, a transcription factor controlling antioxidant gene expression (Gao 
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et al., 2007). In this context, we decided to study several antioxidant levels or enzyme 
activities. No changes in Cu/Zn superoxide dismutase, Mn superoxide dismutase, or 
glutathione peroxidase activities were detected after treatment of hepatocytes with DHA. 
Only a slight increase in glutathione levels was obtained upon DHA exposure compared to 
control cells and without any further elevation compared to ethanol. In addition, DHA did not 
induce any elevation of lipid peroxidation in total membranes. It was also previously reported 
in blood platelets, that DHA could exert anti-oxidant effects at low doses (0.5 µM) whereas a 
lipid peroxidation was induced at higher concentrations (50 µM) (Lagarde et al., 2012; 
Véricel et al., 2003). Unlike these results, we have found that in rat hepatocytes, DHA 
cytoprotection increased with concentration (50 to 300 µM) (data not shown). Taken 
altogether, these data strongly suggested the absence of a direct antioxidant effect of DHA in 
rat hepatocytes, but highlighted the main role of lipid rafts. In addition, it should be noted 
that, in endothelial cells, DHA was also demonstrated to suppress ROS-induced calcium 
influx via lipid raft alterations (Ye et al., 2010). However, one cannot yet exclude an 
antioxidant effect of DHA metabolites. Indeed, Gonzalez- Périz et al. (2006) reported that 
derived lipid mediators generated from DHA metabolism, namely protectin D1 and 17S-
hydroxy-DHA, protected from carbon tetrachloride- or H2O2-induced lipid peroxidation in 
murine liver or hepatocytes, respectively. From our data, it appears that the main DHA target, 
responsible for its antioxidant effect, may be plasma membrane. Consequently, DHA might 
be proposed for the prevention/treatment of alcoholic liver diseases, either alone or associated 
with other "anti-oxidant" therapies such as vitamin E, silymarin, quercetin, N-acetylcysteine 
or S-adenosylmethionine, that display other mechanisms of action. As accumulating 
experimental evidences both in vitro and in vivo supported the critical role of oxidative stress 
in ethanol-induced liver injury (Albano, 2008; Cohen et al., 2011; Feldstein and Bailey, 2011; 
Wu and Cederbaum, 2009; Zhu et al., 2012), it is essential to propose the development of 
new antioxidant strategies. Indeed, no convincing results have been obtained yet from clinical 
trials with the different antioxidants quoted above (Bergheim et al, 2004; Bjelakovic et al., 
2012; Singal et al., 2011; Tome and Lucey, 2004; Zhu et al., 2012). In this context, bench to 
bedside research to test the DHA efficacy in alcoholic liver disease, used either alone or 
combined with other antioxidant compounds, should be encouraged. 
In summary, our data indicated that DHA significantly reduced ethanol-induced oxidative 
stress and cell death in rat hepatocytes. This effect was demonstrated, for the first time, to be 
likely associated with lipid raft alteration leading to the inhibition of ethanol-induced raft 
clustering and PLCγ1 translocation into lipid rafts (Figure 7). Consequently, DHA inhibited 
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PLCγ 1 activation and hence the lysosome accumulation responsible for the elevation of 
cellular content of LMW iron, a potent pro-oxidant factor. Finally, intake of n-3 PUFA, 
provided that it is DHA, might represent a good preventive approach for patients with 
alcoholic liver disease based upon raft targeting, as it was previously described for cancer 
(Mollinedo and Gajate, 2010; Mollinedo et al., 2010).  
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Legends to figures 

Figure 1. DHA induced protective effect towards ethanol-induced toxicity in primary rat 
hepatocytes evaluated by (A) cell death and (B-D) oxidative stress. Oxidative stress was 
assessed by (B) ROS production and (C-D) lipid peroxidation ((C) oxidation of C11-
BODIPY581/591, a polyunsaturated fatty acid like, and (D) dosage of free 4-hydroxynonenal, 
an oxidized fatty acid by-product). Rat hepatocytes were pretreated for 18 hours with 200 µM 
DHA before 50 mM ethanol addition or not for a further 1- or 5-hours incubation. Some 
cultures were not pre-incubated with DHA. Cell death was determined by staining nuclear 
chromatin condensation with Hoechst 33342 (5-hours treatment with ethanol). ROS 
*** 
P < 0.001 
(A) 
P < 0.01 
** 
(D) 
P < 0.001 
*** 
(B) 
*** 
P < 0.001 
(C) 
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production was analyzed by the fluorescence of DHE (1-hour treatment with ethanol). The 
oxidation of C11-BODIPY581/591 was measured by the relative fluorescence of oxidized 
probe/total probe (5-hours treatment with ethanol). 4-hydroxynonenal was measured by GC-
MS (5-hours treatment with ethanol). Values are the mean ± SD of three independent 
experiments. Ethanol-treated cultures versus cultures without ethanol: **P < 0.01, ***P< 
0.001. 
 
 
Figure 2. DHA did not increase the antioxidant status of ethanol-treated hepatocytes : (A) 
Cu,Zn superoxide dismutase, (B) Mn superoxide dismutase, (C) gluthatione peroxidase 
activities, and (D) glutathione concentration. Rat hepatocytes were pretreated for 18 hours 
with 200 µM DHA before 50 mM ethanol addition or not for a further 5-hours incubation. 
Some cultures were not pre-incubated with DHA. Intracellular antioxidants were tested by 
colorimetric assays. Values are the mean ± SD of three independent experiments. Ethanol-
treated cultures versus cultures without ethanol: *P < 0.05. 
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Figure 3. DHA modified composition of lipid rafts evaluated by (A) total fatty acid profile 
(SFA: saturated fatty acids, MUFA: monounsaturated fatty acids, PUFA: polyunsaturated 
fatty acids), (B) DHA content, (C) cholesterol amount, (D) flotillin expression. Rat 
hepatocytes were pretreated for 18 hours with 200 M DHA. Lipid rafts were obtained after 
lysis of hepatocytes in ice-cold 1% Triton X-100 and fractionation on a sucrose density 
gradient by ultracentrifugation. Lipids from each detergent-resistant raft fractions (1-6) were 
extracted before separation by gas chromatography equipped with a flame ionization detector. 
An equal protein amount of each fraction was submitted to western blotting for analysis of 
. 
(C) 
(A) 
# # 
#
  
# # 
(B) 
# 
- 
DHA 
Rafts Non rafts 
 1      2      3      4    5      6       7       8     9    10    11   
(D) 


flotillin-1 expression. One representative of three independent experiments is shown. Values 
are the mean ± SD of three independent experiments. DHA-treated versus untreated cultures : 
#P< 0.05 and # #P < 0.01. 
 
 
Figure 4. Structural perturbation of lipid rafts by DHA protected from ethanol-induced lipid 
raft clustering : (A) lipid raft membrane fluidity, (B) lipid raft aggregation, (C) lipid raft 
protein interactions. Rat hepatocytes were pretreated for 18 hours with 200 µM DHA before 
50 mM ethanol addition or not for a further 1-hour incubation. Lipid rafts were obtained after 
lysis of hepatocytes in ice-cold 1% Triton X-100 and fractionation on a sucrose density 
gradient by ultracentrifugation. (A) Membrane fluidity was monitored by electron 
paramagnetic resonance analysis of 12-doxyl stearic acid embedded in membranes. This 
analysis resulted in the determination of the order parameter S which is inversely related to 
membrane fluidity. (B) Lipid raft aggregation was visualized by fluorescence microscopy 
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with cholera toxin subunit B conjugated with Alexa Fluor 488 which binds the raft-associated 
glycosphingolipid GM1. One representative of three independent experiments is shown. (C) 
Protein structural changes were examined with tetramethyl-4-maleimidopiperidine- 1-oxyl 
(MAL-6), a thiol-specific protein spin label. Values are the mean ± SD of three independent 
experiments. Ethanol-treated versus cultures without ethanol: *P< 0.05, **P < 0.01, ***P< 
0.001. DHA-treated versus untreated cultures: #P< 0.05, # #P < 0.01 and # # #P< 0.001. NS : 
not significant. 
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Figure 5. DHA inhibited ethanol-induced phospholipase Cγ1 translocation into lipid rafts (A) 
and subsequent activation (B). Rat hepatocytes were pretreated for 18 hours with 200 µM 
DHA, before 50 mM ethanol addition or not for a further 1-hour incubation. (A) Rat 
hepatocytes were co-stained by Alexa Fluor cholera toxin subunit B (CTX; green 
fluorescence at left) and tetramethyl rhodamine isothiocyanate (TRITC)- conjugated antigen 
to phospholipase Cγ1 (anti-PLCγ1; red fluorescence in middle). The merge of both images 
shows yellow areas (at right) that represent colocalization of 
monosialotetrahexosylganglioside and PLCγ1. One representative of three independent 
experiments is shown. (B) Lipid rafts were obtained after lysis of hepatocytes in ice-cold 1% 
Triton X-100 and fractionation on a sucrose density gradient by ultracentrifugation, and then 
analyzed for alkaline phosphatase activity which is inversely related to PLCγ1 activity. 
Values are the mean ± SD of three independent experiments. Ethanol-treated versus cultures 
without ethanol: ***P< 0.001. DHA-treated versus untreated cultures: # # #P< 0.001. 
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Figure 6. DHA prevented ethanol-induced lysosome accumulation (A) and subsequent 
elevation of cellular LMW iron content (B). Rat hepatocytes were pretreated for 18 hours 
with 200 µM DHA, before 50 mM ethanol addition or not for a further 1- or 1.5- hour 
incubation. (A) Lysosomes were visualized by fluorescence microscopy using 200 nM 
LysoTracker, a lysosomal marker. Lysosomes were characterized by bright red fluorescence 
(1-hour treatment with ethanol). One representative of three independent experiments is 
** 
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shown (B) Low-molecular-weight iron was determined by EPR analysis after chelation by 3 
mM deferiprone (1.5-hour treatment with ethanol). Values are the mean ± SD of three 
independent experiments. Ethanol-treated versus cultures without ethanol: **P< 0.01.  
 
 
Figure 7. Proposed mechanism for the role of lipid rafts in the protection provided by DHA 
against ethanol-induced oxidative stress and cell death in rat hepatocytes. DHA, by its 
incorporation into lipid rafts, might generate non raft regions inside lipid rafts preventing 
from ethanol-induced lipid raft clustering and hence PLCγ1 translocation into rafts. 
Consequently, DHA would inhibit ethanol-induced oxidative stress and cell death. 
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